2022-01-13 08:02:36 ALV Autoliv
Aptiv
01/13/22 01/1308:02 01/13/2208:02 | Deutsche Bank sees 2022 guidance misses from these auto companiesDeutsche Bank analyst Emmanuel Rosner sees potential for "notable 2022 guidance misses" from Autoliv (ALV), Aptiv (APTV) and Visteon (VC), followed by American Axle (AXL), Lear (LEA) and Dana (DAN). Further, Adient (ADNT) is potentially a "miss and cut" candidate, Rosner tells investors in a research note previewing the Q4 earnings and 2022 outlooks for the autos and auto technology industries. On the other hand, Rosner anticipates 2022 outlooks from General Motors (GM) and Ford (F) to be "solidly in-line or above modest Street expectations." This reflects "unusual concurrent positive industry conditions of volume recovery and robust pricing, offsetting cost inflation," the analyst writes. While not providing direct guidance, he also expects a positive update from Tesla (TSLA) on its growth and margin potential in 2022 and on the cadence of its new products and technology. Autoliv
Aptiv
Visteon
American Axle
Lear
Dana
Adient
General Motors
Ford
|
|
---|
Downgrade
|
Axon downgraded to Equal Weight from Overweight at Morgan Stanley »
06:42 05/23/22 05/2306:42 05/23/2206:42
AXON
Axon
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Roivant Sciences initiated with an Outperform at SVB Leerink »
06:42 05/23/22 05/2306:42 05/23/2206:42
ROIV
Roivant Sciences
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
United Fire Group management to meet with Piper Sandler »
06:42 05/23/22 05/2306:42 05/23/2206:42
UFCS
United Fire Group
Meetings to be held in… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Zebra Technologies upgraded to Equal Weight from Underweight at Morgan Stanley »
06:41 05/23/22 05/2306:41 05/23/2206:41
ZBRA
Zebra Technologies
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Alteryx initiated with an Outperform at FBN Securities »
06:41 05/23/22 05/2306:41 05/23/2206:41
AYX
Alteryx
FBN Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
April delinquency trends promising for Affirm, says Mizuho »
06:41 05/23/22 05/2306:41 05/23/2206:41
AFRM
Affirm
Mizuho analyst Dan Dolev… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Frontdoor downgraded to Hold from Buy at Truist »
06:41 05/23/22 05/2306:41 05/23/2206:41
FTDR
Frontdoor
Truist analyst Youssef… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Timken management to meet with Loop Capital »
06:40 05/23/22 05/2306:40 05/23/2206:40
TKR
Timken
Meetings to be held in CA… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
TreeHouse upgraded to Buy from Hold at Truist »
06:40 05/23/22 05/2306:40 05/23/2206:40
THS
TreeHouse
Truist analyst Bill… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Upwork initiated with a Sector Perform at RBC Capital »
06:40 05/23/22 05/2306:40 05/23/2206:40
UPWK
Upwork
Microsoft
RBC Capital analyst Brad… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Radius Health initiated with a Market Perform at SVB Leerink »
06:40 05/23/22 05/2306:40 05/23/2206:40
RDUS
Radius Health
Amgen
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
American Vanguard issues stockholder letter in support of director nominees »
06:38 05/23/22 05/2306:38 05/23/2206:38
AVD
American Vanguard
American Vanguard sent a… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Pfizer initiated with a Market Perform at SVB Leerink »
06:38 05/23/22 05/2306:38 05/23/2206:38
PFE
Pfizer
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Ocugen: FDA removes clinical hold on Phase 2/3 clinical trial for COVAXIN »
06:37 05/23/22 05/2306:37 05/23/2206:37
OCGN
Ocugen
Ocugen announced that the… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Nvidia price target lowered to $280 from $350 at UBS »
06:37 05/23/22 05/2306:37 05/23/2206:37
NVDA
Nvidia
UBS analyst Timothy… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Eli Lilly initiated with an Outperform at SVB Leerink »
06:36 05/23/22 05/2306:36 05/23/2206:36
LLY
Eli Lilly
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Sumitomo Pharma downgraded to Neutral from Buy at Citi »
06:36 05/23/22 05/2306:36 05/23/2206:36
DNPUF
Sumitomo Pharma
Citi analyst Hidemaru… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Musk's planned takeover of Twitter creates 'chaos tax,' WSJ reports »
06:34 05/23/22 05/2306:34 05/23/2206:34
TWTR
Within 24-hours,… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Electronic Arts reportedly looking to sell or merge, Kotaku reports »
06:34 05/23/22 05/2306:34 05/23/2206:34
EA
Electronic Arts
Comcast
Disney
Apple
Microsoft
Activision Blizzard
EA (EA) recently pursued… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Syros Pharmaceuticals management to meet virtually with Oppenheimer »
06:34 05/23/22 05/2306:34 05/23/2206:34
SYRS
Syros Pharmaceuticals
Virtual Meeting to be… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Halozyme initiated with an Outperform at SVB Leerink »
06:34 05/23/22 05/2306:34 05/23/2206:34
HALO
Halozyme
Antares Pharma
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Realty Income downgraded to Peer Perform from Outperform at Wolfe Research »
06:33 05/23/22 05/2306:33 05/23/2206:33
O
Realty Income
Wolfe Research analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
JBG Smith downgraded to Peer Perform from Outperform at Wolfe Research »
06:33 05/23/22 05/2306:33 05/23/2206:33
JBGS
JBG Smith Properties
Wolfe Research analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
ImmunoGen's BLA for mirvetuximab soravtansine in ovarian cancer accepted by FDA »
06:32 05/23/22 05/2306:32 05/23/2206:32
IMGN
ImmunoGen
ImmunoGen announced that… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Johnson & Johnson assumed with an Outperform at SVB Leerink »
06:31 05/23/22 05/2306:31 05/23/2206:31
JNJ
Johnson & Johnson
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|